Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05447611

Role of Empathy in Curative Treatment Outcomes of Non-metastatic Colorectal Cancer.

Role of Empathy in the Outcome of Curative Treatment of Non-metastatic Colorectal Cancer. Prospective Multicenter Longitudinal Study in Two Departments Covered by the Calvados Cancer Registry.

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
University Hospital, Caen · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The aim of project EMPACOL will be to investigate, while taking into consideration the clinical factors known and well described in the literature, among the non-clinical factors, in particular, patient-healthcare personnel (HCP) relationship, a link between HCP's empathy perceived by the patient, and the results of the curative treatment of non-metastatic colorectal cancer, throughout the patient's care.

Detailed description

EMPACOL will be a multicenter prospective longitudinal study. Over a 2-year period, in two French areas covered by a cancer register, 8 centers will include patients with non-metastatic CRC, uncomplicated at diagnosis Based on the curative treatment strategy, patients will be divided into three groups: group 1 (surgery alone), group 2 (surgery and adjuvant chemotherapy), group 3 (neo-adjuvant therapy, surgery and adjuvant chemotherapy). The relationship between HCP's empathy, perceived by the patient, after 2 years of inclusion, and the quality of life (QoL) at one year after the end of treatment will be investigated. QoL will be investigated using the QLQ C-30 questionnaire. Finally, a link between PHC perception and oncological outcomes will be sought.

Conditions

Timeline

Start date
2022-09-01
Primary completion
2024-09-01
Completion
2029-09-01
First posted
2022-07-07
Last updated
2022-07-07

Source: ClinicalTrials.gov record NCT05447611. Inclusion in this directory is not an endorsement.